Profile
TAK ZTS HLN TEVA NBIX ITCI
Company Name Takeda Pharmaceutical Company Limited Zoetis Inc. Haleon plc Teva Pharmaceutical Industries Limited Neurocrine Biosciences, Inc. Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $42.85B $63.86B $42.64B $27.49B $15.29B $14.05B
Employees 49.28K 13.80K 24.56K 37.00K 1.80K 0.86K
CEO Christophe Weber Kristin C. Peck Brian James McNamara Richard D. Francis Kyle W. Gano Sharon Mates
Ratings
TAK ZTS HLN TEVA NBIX ITCI
Quant Rating Score 3 3 3 3 4 1
Quant Rating Neutral Neutral Neutral Neutral Buy Strong Sell
Trading
TAK ZTS HLN TEVA NBIX ITCI
Last Close $13.66 $120.24 $9.46 $23.97 $152.37 $131.87
High 52 $15.52 $178.71 $11.41 $24.6 $154.8 $131.91
Low 52 $12.89 $119.56 $8.73 $12.82 $87.59 $81.78
Price vs. 52 Week High -11.98 % -32.72 % -17.09 % -2.56 % -1.57 % -0.03 %
Price vs. 52 Week Low 5.97 % 0.57 % 8.36 % 86.97 % 73.96 % 61.25 %
Total Return
TAK ZTS HLN TEVA NBIX ITCI
1 Month Return -4.54 % -16.26 % 4.53 % 18.6 % 9.62 % 0 %
3 Month Return -5.4 % -18.4 % -0.84 % 46.43 % 21.9 % 0 %
6 Month Return -4.27 % -25.64 % -10.5 % 32.65 % 29.65 % 0 %
9 Month Return 0.96 % -29.86 % -0.94 % 42.26 % 24.89 % 3.83 %
YTD Return 3.17 % -26.2 % -0.84 % 8.76 % 11.63 % 57.89 %
1 Year Return -0.87 % -32 % -1.56 % 40.09 % 21.18 % 44.45 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
TAK ZTS HLN TEVA NBIX ITCI
Dividend Yield Percentage (TTM) 4.72 % 1.34 % 1.57 % - - -
Dividend Paid and Capex Coverage Ration (TTM) 2.01 % 1.89 % 2.01 % 2.78 % 14.57 % -121.31 %
Dividend Per Share (TTM) 198 % 1.93 % 0.06 % - - -
Payout Ratio (TTM) 226.17 % 32.08 % 27.27 % - - -
Profitability
TAK ZTS HLN TEVA NBIX ITCI
Gross Profit Margin TTM 52.77 % 70.03 % 61.81 % 49.6 % 98.37 % 91.22 %
Return on Assets TTM 0.98 % 18.04 % 4.78 % -0.39 % 10.03 % -4.35 %
Return on Equity TTM 1.95 % 53.21 % 9.4 % -2.58 % 15.82 % -5.19 %
Return on Capital Employed TTM 4.8 % 31.67 % 8.34 % 3.16 % 15.17 % -8.25 %
Net Income Per EBT TTM 72.4 % 78.72 % 76.52 % 222.54 % 68.09 % 100.19 %
EBT Per Ebit TTM 33.29 % 94.26 % 88.09 % -7.94 % 114.25 % 61.94 %
EBIT Per Revenue TTM 12.68 % 37.51 % 20.49 % 5.38 % 20.51 % -17.88 %
Cash Flow To Debt Ratio TTM 22.35 % 43.13 % 12.02 % 7.93 % 148.65 % -230.03 %
Receivables Turnover TTM 6.59 6.09 5.14 4.67 3.69 3.22
Payables Turnover TTM 5.02 5.54 1.18 3.35 0.37 1.8
Inventory Turnover TTM 1.71 1.15 3.72 2.4 0.63 1.79
Fixed Asset Turnover TTM 229.02 % 244.46 % 589.57 % 321.73 % 473.81 % 3596.74 %
Asset Turnover TTM 31.99 % 64.82 % 34.62 % 41.43 % 62.89 % 39.2 %
Operating Cash Flow Per Share TTM 643.53 6.58 0.11 1.21 6.41 -0.38
Free Cash Flow Per Share TTM 521.29 4.99 0.1 0.78 5.97 -0.38
Cash Per Share TTM 22368.59 % 322.4 % 7.46 % 188.4 % 1121.53 % 970.67 %
Operating Cash Flow Sales Ratio TTM 22.48 % 31.21 % 9.32 % 8.36 % 23.74 % -7.29 %
Free Cash Flow Operating Cash Flow Ratio TTM 81.01 % 75.76 % 90.65 % 64.03 % 93.14 % 100.82 %
Cash Flow Coverage Ratios TTM 22.35 % 43.13 % 12.02 % 7.93 % 148.65 % -230.03 %
Price To Free Cash Flows Ratio TTM 8.1 28.78 34.18 31.28 25.77 -356.68
Price To Operating Cash Flows Ratio TTM 6.51 21.9 31.51 20.02 24 -348.17
Price Cash Flow Ratio TTM 6.51 21.9 31.51 20.02 24 -348.17
Income Statement (TTM)
TAK ZTS HLN TEVA NBIX ITCI
Revenue $4581.55B $9.26B $11.23B $16.54B $2.36B $0.68B
Gross Profit $3001.33B $6.4B $6.95B $8.06B $2.32B $0.62B
Gross Profit Ratio 65.51% 69.1% 61.85% 48.74% 98.56% 91.63%
EBITDA $1210.51B $3.87B $2.51B $0.78B $0.64B $-0.12B
Net Income $107.93B $2.49B $1.44B $-1.64B $0.34B $-0.07B
EPS Diluted 33.62 5.47 0.32 -1.45 3.29 -0.72
Balance Sheet (MRQ)
TAK ZTS HLN TEVA NBIX ITCI
Long Term Debt $4517.23B $5.39B $8.62B $16.3B $0.46B $0.01B
Total Liabilities $7312.37B $9.47B $18.09B $33.61B $1.13B $0.22B
Total Equity $6935.98B $4.77B $16.22B $5.72B $2.59B $1.15B
Total Investments $382.4B $0.03B $0.08B $0B $1.71B $0.69B
Total Debt $5066.17B $6.74B $10.1B $18.08B $0.46B $0.02B
Total Assets $14248.34B $14.24B $34.32B $39.33B $3.72B $1.37B
Cash Flow Statement (TTM)
TAK ZTS HLN TEVA NBIX ITCI
Net Income $107.93B $2.5B $1.44B $-1.96B $0.34B $-0.07B
Inventory $-34.97B $-0.04B $0.22B $0.17B $-0.02B $-0.01B
Dividends Paid $-302.5B $-0.79B $-0.57B $0B $0B $0B
Operating Cash Flow $1057.18B $2.95B $2.3B $1.25B $0.6B $-0.07B
Capital Expenditure $-200.8B $-0.66B $-0.25B $-0.5B $-0.04B $-0B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.55
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.33
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 5.71
ALVOW Alvotech 0.62
AMPH Amphastar Pharmaceuticals, Inc. 24.03
AMRX Amneal Pharmaceuticals, Inc. 11.37
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 90.43
APUS Apimeds Pharmaceuticals US, Inc 2.23
AQST Aquestive Therapeutics, Inc. 6.04
ASRT Assertio Holdings, Inc. 0.7605
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 18.69
ETFs With Exposure to TAK
Ticker ETF Name Weight Percentage Price
VEU Vanguard FTSE All-World ex-US Index Fund 0.00198 72.32
FVD First Trust Value Line Dividend Index Fund 0.000001 45.58
CVY Invesco Zacks Multi-Asset Income ETF 0.432 26.375
GCOW Pacer Global Cash Cows Dividend ETF 0.74 40.26
AFTY Pacer CSOP FTSE China A50 ETF 0.27 16.2826
AGGY WisdomTree Yield Enhanced U.S. Aggregate Bond Fund 0.04 44.2
FPXI First Trust International Equity Opportunities ETF 2.11 58.5597
ICOW Pacer Developed Markets International Cash Cows 100 ETF 1.77 37.725
PPH VanEck Pharmaceutical ETF 2.33 93.89
VETS Pacer Military Times Best Employers ETF 0.18 38.62
ACSG Xtrackers MSCI ACWI ex USA ESG Leaders Equity ETF 0.37 39.7776
PTIN Pacer Trendpilot International ETF 0.18 30.9614
VALT ETFMG Sit Ultra Short ETF 0.77 48.52
SLT Pacer Salt High truBeta US Market ETF 0.18 39.22
LSLT Pacer Salt Low truBeta US Market ETF 0.18 32
AVDE Avantis International Equity ETF 0.05 79.18
GERM ETFMG Treatments, Testing and Advancements ETF 0.89 19.1577
VIRS Pacer BioThreat Strategy ETF 0.18 40.025
FVL First Trust Value Line 100 Exchange-Traded Fund 0.000001 23.1559
SILX ETFMG Prime 2x Daily Junior Silver Miners ETF 0.73 1.75
RTL The Necessity Retail REIT, Inc. 0.27 7.61
BAD B.A.D. ETF 1.51 11.91
AVSD Avantis Responsible International Equity ETF 0.05 71.455
DFIC Dimensional International Core Equity 2 ETF 0.00087487 32.915
VFWAX Vanguard FTSE All-World ex-US Index Fd Admiral 0.00198 44.87
DFAX Dimensional World ex U.S. Core Equity 2 ETF 0.00075105 31.61
TRPL Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF 0.18 41.14
VEU.AX Vanguard All-World ex-US Shares Index ETF 0.00211 111.34
OZEM Roundhill GLP-1 & Weight Loss ETF 1.92 29.4878
CGCV Capital Group Conservative Equi 0.1 29.95
ENDW Cambria Endowment Style ETF 0 30.541
Unlock